An alternative synthesis of a potent GPIIb/IIIa receptor antagonist

被引：0
|
作者：
Hayes, JF [1 ]
机构：
[1] SmithKline Beecham Pharmaceut, Tonbridge TN11 9AN, Kent, England
来源：
SYNLETT | 1999年
关键词：
benzodiazepine; cyclization; quinone; hydroquinone; oxidation;
D O I：
暂无
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
A key intermediate to SE-214857 was prepared via an oxidative cyclization of a hydroquinone with a flanking aspartate side chain using Fremy's salt.
引用
收藏
页码：865 / 866
页数：2
相关论文
共 50 条
  • [41] Eptifibatide -: Integrilin® -: Platelet antiaggregatory -: Fibrinogen gpIIb/IIIa antagonist
    不详
    DRUGS OF THE FUTURE, 2000, 25 (06) : 632 - 633
  • [42] Identification and characterization of antibodies that bind GPIIb/IIIa: Antagonist complexes
    Breth, L
    Kochie, J
    Combs, A
    Wang, S
    Smallheer, J
    Billheimer, J
    Selffert, D
    Hollis, G
    O'Neil, K
    JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 301 (1-2) : 11 - 20
  • [43] UR-3216: A manageable oral GPIIb/IIIa antagonist
    Baba, K
    Aga, Y
    Nakanishi, T
    Motoyama, T
    Ueno, H
    CARDIOVASCULAR DRUG REVIEWS, 2001, 19 (01): : 25 - 40
  • [44] GPIIb/IIIa antagonist isoxazolinylacetamides having a modified amide linkage
    Wityak, J
    Batt, DG
    Tobin, AE
    Mousa, SA
    Racanelli, AL
    Hausner, EA
    Olson, RE
    Wexler, RR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 96 - MEDI
  • [45] Quantitative detection of platelet GPIIb-IIIa receptor antagonist activity using a flow cytometric method
    Green, LJ
    Marder, P
    Um, SL
    Jakubowski, JA
    Lawrence, JB
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1998, 12 (04) : 191 - 196
  • [46] Intranasal antiplatelet/antithrombotic efficacy of a novel platelet GPIIB/IIIA receptor antagonist DMP755
    Mousa, SA
    Mu, DX
    Hussain, MA
    THROMBOSIS RESEARCH, 1998, 92 (03) : 115 - 124
  • [47] Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802
    Mousa, SA
    Olson, RE
    Bozarth, JM
    Lorelli, W
    Forsythe, MS
    Racanelli, A
    Gibbs, S
    Schlingman, K
    Bozarth, T
    Kapil, R
    Wityak, J
    Sielecki, TM
    Wexler, RR
    Thoolen, MJ
    Slee, A
    Reilly, TM
    Anderson, PS
    Friedman, PA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (02) : 169 - 176
  • [48] Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs
    Rebello, SS
    Kasiewski, CJ
    Bentley, RG
    Morgan, SR
    Chu, V
    Bostwick, JS
    Klein, SI
    Perrone, MH
    Leadley, RJ
    THROMBOSIS RESEARCH, 2001, 102 (03) : 261 - 271
  • [49] Discovery of a novel non peptide antiplatelet GPIIb/IIIa receptor antagonist, DMP 754: Receptor binding affinity and specificity
    Mousa, SA
    Bozarth, J
    Forsythe, M
    Xue, CB
    Wityak, J
    Olson, R
    Thoolen, MJ
    Reilly, TM
    CIRCULATION, 1996, 94 (08) : 3006 - 3006
  • [50] Antiplatelet efficacy of orally administered DMP802, a GPIIb/IIIa receptor antagonist, in the conscious dog
    Reilly, TM
    Racanelli, AL
    Olson, RE
    Wityak, J
    Wexler, RR
    Hausner, EA
    Thoolen, MJ
    Mousa, SA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 7122 - 7122
12345